John A. Morrow

Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases

Martin Steger, Francesca Tonelli, Genta Ito et al. · eLife · 2016 · 1K citations · Full text

Mitophagy, Molecular Biology, Rab Gtpases +16

The VIP₂ receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide

E.M. Lutz, W. John Sheward, West Km et al. · FEBS Letters · 1993 · 494 citations

Immunology, Gastrointestinal Peptide Hormone, Molecular Pharmacology +18

MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition

Matthew Fell, Christian Mirescu, Kallol Basu et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 326 citations · Full text

Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity

Jack D. Scott, Duane E. DeMong, Thomas J. Greshock et al. · Journal of Medicinal Chemistry · 2017 · 140 citations · Full text

Drug Target, Pharmacotherapy, Medicinal Chemistry +16

Molecular cloning and expression of a cDNA encoding a receptor for pituitary adenylate cyclase activating polypeptide (PACAP)

John A. Morrow, E.M. Lutz, West Km et al. · FEBS Letters · 1993 · 125 citations · Full text

Gastrointestinal Peptide Hormone, Pituitary Gland, Pituitary Disease +18